Biological & pharmaceutical bulletinHumansPsoriasisArthritisRheumatoidFemale
Comparison of the Risk of Paradoxical Psoriasis between Monoclonal Antibody and Non-monoclonal Antibody Tumor Necrosis Factor-α Inhibitors in Patients with Rheumatoid Arthritis: An Observational Study Using a Claims Database.
Minoru Shimazaki, Yutaka Matsuyama, Daisuke Koide
Published: 202510.1248/bpb.b25-00058
Abstract
Tumor necrosis factor-α inhibitors (TNFis) are associated with a risk of paradoxical psoriasis, but quantitative data remain limited. One proposed mechanism is the induction of interferon (IFN) production following TNFi administration. Etanercept and…
Preview only. Read the full abstract at the source